Carr, Stuart
Pratt, Rebecca
White, Fred
Watson, Wade
Article History
Received: 27 May 2024
Accepted: 13 November 2024
First Online: 9 December 2024
Declarations
:
: Ethics approval and consent to participate are not applicable to this review article.
: Not applicable.
: Dr. Stuart Carr has participated in speaker’s bureaus and advisory boards with Sanofi. Dr. Rebecca Pratt has received consulting fees and honoraria for continuing education sessions from Merck, Medexus, Novartis, Astrazenca, GSK, Sanofi, Covis, Aralez, Stallergens-Greer, Bausch, AbbVie and ALK. Dr. Fred White: none. Dr. Wade Watson is medical advisor for Food Allergy Canada.None of the authors received any incentive or funding for the preparation or review of the manuscript.
: This article has been published as part of Allergy, Asthma & Clinical Immunology, Volume 20 Supplement 03, 2024: Practical Guide for Allergy and Immunology in Canada 2024. The full contents of the supplement are available at .